Nature Communications (May 2024)
A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations
- Ingrid M. Saldana-Guerrero,
- Luis F. Montano-Gutierrez,
- Katy Boswell,
- Christoph Hafemeister,
- Evon Poon,
- Lisa E. Shaw,
- Dylan Stavish,
- Rebecca A. Lea,
- Sara Wernig-Zorc,
- Eva Bozsaky,
- Irfete S. Fetahu,
- Peter Zoescher,
- Ulrike Pötschger,
- Marie Bernkopf,
- Andrea Wenninger-Weinzierl,
- Caterina Sturtzel,
- Celine Souilhol,
- Sophia Tarelli,
- Mohamed R. Shoeb,
- Polyxeni Bozatzi,
- Magdalena Rados,
- Maria Guarini,
- Michelle C. Buri,
- Wolfgang Weninger,
- Eva M. Putz,
- Miller Huang,
- Ruth Ladenstein,
- Peter W. Andrews,
- Ivana Barbaric,
- George D. Cresswell,
- Helen E. Bryant,
- Martin Distel,
- Louis Chesler,
- Sabine Taschner-Mandl,
- Matthias Farlik,
- Anestis Tsakiridis,
- Florian Halbritter
Affiliations
- Ingrid M. Saldana-Guerrero
- Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield
- Luis F. Montano-Gutierrez
- St. Anna Children’s Cancer Research Institute (CCRI)
- Katy Boswell
- Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield
- Christoph Hafemeister
- St. Anna Children’s Cancer Research Institute (CCRI)
- Evon Poon
- Division of Clinical Studies, The Institute of Cancer Research (ICR) & Royal Marsden NHS Trust
- Lisa E. Shaw
- Department of Dermatology, Medical University of Vienna
- Dylan Stavish
- Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield
- Rebecca A. Lea
- Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield
- Sara Wernig-Zorc
- St. Anna Children’s Cancer Research Institute (CCRI)
- Eva Bozsaky
- St. Anna Children’s Cancer Research Institute (CCRI)
- Irfete S. Fetahu
- St. Anna Children’s Cancer Research Institute (CCRI)
- Peter Zoescher
- St. Anna Children’s Cancer Research Institute (CCRI)
- Ulrike Pötschger
- St. Anna Children’s Cancer Research Institute (CCRI)
- Marie Bernkopf
- St. Anna Children’s Cancer Research Institute (CCRI)
- Andrea Wenninger-Weinzierl
- St. Anna Children’s Cancer Research Institute (CCRI)
- Caterina Sturtzel
- St. Anna Children’s Cancer Research Institute (CCRI)
- Celine Souilhol
- Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield
- Sophia Tarelli
- Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield
- Mohamed R. Shoeb
- St. Anna Children’s Cancer Research Institute (CCRI)
- Polyxeni Bozatzi
- St. Anna Children’s Cancer Research Institute (CCRI)
- Magdalena Rados
- St. Anna Children’s Cancer Research Institute (CCRI)
- Maria Guarini
- CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
- Michelle C. Buri
- St. Anna Children’s Cancer Research Institute (CCRI)
- Wolfgang Weninger
- Department of Dermatology, Medical University of Vienna
- Eva M. Putz
- St. Anna Children’s Cancer Research Institute (CCRI)
- Miller Huang
- Children’s Hospital Los Angeles, Cancer and Blood Disease Institutes, and The Saban Research Institute
- Ruth Ladenstein
- St. Anna Children’s Cancer Research Institute (CCRI)
- Peter W. Andrews
- Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield
- Ivana Barbaric
- Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield
- George D. Cresswell
- St. Anna Children’s Cancer Research Institute (CCRI)
- Helen E. Bryant
- Sheffield Institute for Nucleic Acids (SInFoNiA), School of Medicine and Population Health, The University of Sheffield
- Martin Distel
- St. Anna Children’s Cancer Research Institute (CCRI)
- Louis Chesler
- Division of Clinical Studies, The Institute of Cancer Research (ICR) & Royal Marsden NHS Trust
- Sabine Taschner-Mandl
- St. Anna Children’s Cancer Research Institute (CCRI)
- Matthias Farlik
- Department of Dermatology, Medical University of Vienna
- Anestis Tsakiridis
- Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield
- Florian Halbritter
- St. Anna Children’s Cancer Research Institute (CCRI)
- DOI
- https://doi.org/10.1038/s41467-024-47945-7
- Journal volume & issue
-
Vol. 15,
no. 1
pp. 1 – 25
Abstract
Abstract Early childhood tumours arise from transformed embryonic cells, which often carry large copy number alterations (CNA). However, it remains unclear how CNAs contribute to embryonic tumourigenesis due to a lack of suitable models. Here we employ female human embryonic stem cell (hESC) differentiation and single-cell transcriptome and epigenome analysis to assess the effects of chromosome 17q/1q gains, which are prevalent in the embryonal tumour neuroblastoma (NB). We show that CNAs impair the specification of trunk neural crest (NC) cells and their sympathoadrenal derivatives, the putative cells-of-origin of NB. This effect is exacerbated upon overexpression of MYCN, whose amplification co-occurs with CNAs in NB. Moreover, CNAs potentiate the pro-tumourigenic effects of MYCN and mutant NC cells resemble NB cells in tumours. These changes correlate with a stepwise aberration of developmental transcription factor networks. Together, our results sketch a mechanistic framework for the CNA-driven initiation of embryonal tumours.